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Abstract
Background: Feline morbillivirus (FmoPV) is a novel paramyxovirus found to infect domestic cats. FmoPV has been
isolated in several countries in Asia and Europe and is considered to have genetic diversity. Also, it is suspected to
be associated with feline renal diseases including tubulointerstitial nephritis (TIN), which affects domestic cats with
a high incidence rate.
Results: To clarify the state of FmoPV infection among domestic cats in Japan, an epidemiological survey was
conducted. Twenty-one out of 100 cats were found to have serum antibodies (Ab) against FmoPV-N protein by
indirect immunofluorescence assay (IF) using FmoPV-N protein-expressing HeLa cells. Twenty-two of the cats were
positive for FmoPV RNA in the urine and/or renal tissues. In total, 29 cats were positive for Ab and/or viral RNA.
These FmoPV-infected cats were classified into three different phases of infection: RNA+/Ab + (14 cats), RNA+/Ab-
(8 cats) and RNA-/Ab + (7 cats). In immunohistochemistry (IHC), 19 out of 29 cats were positive for FmoPV-N protein
in kidney tissues; however, the FmoPV-N protein was located in the inflammatory lesions with severe grade in only
four out of the 19 cats. Since 15 out of 29 infected cats were positive for viral RNA and Ab, approximately half of
the infected cats were persistently infected with FmoPV.
Conclusions: A statistically significant difference was observed between infection of FmoPV and the presence of
inflammatory changes in renal lesions, indicating a relationship between FmoPV infection and feline renal diseases.
However, we could not obtain histopathological evidence of a relationship between FmoPV infection and TIN.
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Background
A novel paramyxovirus, feline morbillivirus (FmoPV),
has recently been detected in domestic cats [1–8].
FmoPV is genetically most closely related to viruses such
as canine distemper virus (CDV), measles virus (MV),
rinderpest virus (RPV), peste-des-petits-ruminants virus
(PPRV), phocine distemper virus (PDV) and cetacean
morbillivirus (CMV), belonging to the genus morbilli-
virus in the family Paramyxoviridae [1–5]. FmoPV
showed genetic diversity among isolates [3–5], and a
natural recombination in the envelope protein region be-
tween viruses in different clades was also found [4]. In
Germany, three groups of feline paramyxoviruses (FPaV)
have been detected, and these were associated with fe-
line chronic kidney diseases (CKD) including lower urin-
ary tract diseases (LUTD) [5]. Phylogenetically, the first
group of these viruses belongs to the same cluster of
FmoPV with 99 % homology, whereas the second group
represents a new cluster between FmoPV and other
morbilliviruses. The third group represents a group that
is distinct from FmoPV and other morbilliviruses. A ser-
oepidemiological survey of CDV infection in Asian
countries showed that domestic cats were susceptible to
CDV infection, but CDV was not virulent in domestic
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cats [9]. At the moment, it is not yet confirmed that
FmoPV is classified in the genus morbillivirus or in a
novel genus separate from the genus morbillivirus.
Kidney failure is one of the most important and com-
mon diseases in domestic cats. It can be divided into
acute kidney disease (AKD) and chronic kidney disease
(CKD), or inherent kidney disease and acquired kidney
disease [10–13]. AKD, which could be caused by toxins,
trauma, infection, shock, blockage of the blood flow and
heart failure [11], is reversible and can affect cats of all
ages. CKD affects domestic cats, especially middle-aged
or older cats [14], and its prevalence increases according
to age, affecting up to half of cats older than 15 years
[14]. CKD could result from infection, blockages, dental
disease, high blood pressure and cancer. In particular,
idiopathic CKD such as pyelonephritis, glomeruloneph-
ritis and chronic tubulointerstitial nephritis (TIN) due to
unknown causes has been reported extensively [10, 11,
15–17]. It is suspected that FmoPV is one of the causa-
tive agents of CKD [1, 5], such as chronic TIN. There-
fore, it is important to clarify the characteristics or the
pathogenicity of FmoPV and the pathogenesis in domes-
tic cats as the natural host. In this respect, large-scale
epidemiological investigation is considered to be
indispensable.
In this study, epidemiological and pathological studies
were performed to demonstrate the seroprevalence of
FmoPV and the relationship between FmoPV and CKD
in Japan. These studies revealed that the infection rate of
FmoPV was considerable and FmoPV might be related
to urinary tract diseases.
Results
Detection of FmoPV by RT-PCR and phylogenetic analysis
Cat urine and renal tissues were examined for the pres-
ence of FmoPV RNA by nested RT-PCR [2]. Seventeen
cats (17 %) were positive for FmoPV RNA in urine, and
18 cats (18 %) were positive in renal tissues (Table 1).
Among these cats, 13 cats (13 %) were both positive in
urine and tissues. Four cats (4 %) were positive in the
urine but negative in the tissues, whereas five cats (5 %)
were negative in the urine but positive in the tissues.
Nucleotide sequences of all the PCR-positive samples
were analyzed phylogenetically with those of FmoPVs in
Hong Kong and Japan (Kyoto), and CDV and Nipah
virus as outgroups. They were divided into three groups
(Fig. 1). To determine the groups of FmoPV strains in
the phylogenetic tree are stable, pairwise distances were
compared by histogram by the method described previ-
ously [18]. Statistically significant differences (P < 0.01)
were obtained in the distribution of the pairwise dis-
tances of clusters A, B and C (data not shown). FmoPV
strains from Hong Kong and some strains of Japan were
grouped into the same clusters, cluster A and C, thus a
phylogenetic relationship with geographic distribution of
FmoPV in two countries was not observed (Fig. 1).
Detection of antibodies against FmoPV-N protein by Im-
munofluorescence (IF) test
To detect FmoPV-N antibodies by IF test, FmoPV-N ex-
pressing HeLa cells were prepared. The specificity of the
IF test was confirmed by serum from rabbit immunized
Table 1 Detection of FmoPV RNA by RT-PCR
In urine (n = 100)
- +
In kidney tissues (n = 100) - 78 4
+ 5 13
Fig. 1 Phylogenetic analysis based on partial L protein sequences of
FmoPV in infected cats in Tokyo. Phylogenic tree was inferred using
the maximum likelihood method in the MEGA6 package. The
percentage of replicate tree in which the associated taxa clustered
together in the bootstrap test (1000 replicates) is shown next to the
branches. The tree is drawn to scale, and the scale bar indicates the
branch length corresponding to 0.05 substitutions per site. The
strains from Hong Kong and Japan (Kyoto) are represented by blue
and green, respectively. Nucleotide sequences of CDV and Nipah
virus are used as outgroups and represented in gray. Information
about the strain names and accession numbers is listed in Table 2.
Statistically significant differences (P < 0.01) were obtained in the
distribution of the pairwise distances of clusters A, B and C
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with the purified FmoPV-N and its pre-immune negative
control rabbit serum. As shown in Fig. 2, FmoPV-N im-
munized rabbit serum reacted to FmoPV-N expressing
HeLa, but not to mock-HeLa cells nor empty plasmid,
pKS336, transfected HeLa cells. Negative control rabbit
serum did not react to any of the HeLa cells. Specificity
of the IF test was also confirmed using FmoPV antibody
positive cat serum (N045) (Fig. 2). Thus, all the cat sera
were tested by the IF test to detect antibodies against
FmoPV-N.
Twenty-one percent of cats had Ab against FmoPV-N
protein (Table 2 and Fig. 2). Ab titers ranged between
1:160 to 1:20,480 or above. The Ab titers appeared to be
high in middle-aged cats (from 4 to 8 years old, Fig. 3),
although not significantly. All the FmoPV antibody posi-
tive cat sera were tested negative by IF test using CDV-
N expressing HeLa cells (data not shown), indicating
there is no serological cross reactivity between CDV-N
and FmoPV-N at least by IF test. There were four pat-
terns: RNA+/Ab + (14 cats), RNA+/Ab- (eight cats) and
RNA-/Ab + (seven cats) (Table 2) and RNA-/Ab- (71
cats, data not shown). In total, 29 out of 100 cats (29 %)
were positive for Ab and/or viral RNA, thus they were
considered to be FmoPV-infected. Fourteen out of 29
cats were positive for viral RNA and Ab, indicating that
approximately half of the infected cats were persistently
infected with FmoPV.
Histopathological examination of FmoPV infection in cat
renal tissues
Histopathological examination was performed to detect
FmoPV in cat renal tissues and to confirm the relation-
ship between virus infection and tubulointerstitial neph-
ritis by hematoxylin and eosin (HE) staining and
immunohistochemistry (IHC) (Fig. 4). Among 29 cases
that showed FmoPV RNA+ and/or Ab+, moderate to se-
vere chronic interstitial nephritis was observed in 16
cases (Table 2 and Fig. 4). Mild infiltration of inflamma-
tory cells into the renal tissues was observed in 10 cases.
Three cases had no lesions. Other lesions including
interstitial fibrosis, glomerulosclerosis, tubular microcys-
tic change, proteinaceous casts and calcification were
observed in some cases (data not shown). Among 71
FmoPV non-infected cats, moderate to severe chronic
interstitial nephritis was observed in 29 cases. No lesions
or mild infiltration of inflammatory cells into the renal
tissues were observed in 25 and 15 cases, respectively.
No statistically significant relationship could be con-
firmed between tubulointerstitial nephritis and the infec-
tion of FmoPV (Table 3, P > 0.05). However, a significant
relationship was found between the presence of inflam-
matory lesions and the infection of FmoPV (Table 4, P <
0.01).
To prepare rabbit antibody against FmoPV-N protein
for the detection of FmoPV antigens, a recombinant
FmoPV-N protein with his-tag at C terminal was
expressed in Sf9 insect cells using a recombinant baculo-
virus. The recombinant FmoPV-N was purified by Ni-
NTA agarose chromatography and was confirmed by
SDS-PAGE (Fig. 5). Two major bands with a molecular
weight of 59 and 40 kDa were observed by SDS-PAGE.
A large band was consistent with the predicted size of
the FmoPV-N, while a small one is thought to be N-
terminal truncated FmoPV-N, since both of them were
purified by Ni-NTA agarose chromatography. Since
FmoPV-positive cat serum reacted to both two bands in
immunoblot, N-terminal truncated FmoPV-N was con-
sidered to be immunogenic. The purified FmoPV-N pro-
tein was subcutaneously injected into three rabbits five
times. When the serum antibody titers by IF test reached
Fig. 2 IF staining. a FmoPV-N immunized rabbit serum strongly reacted to FmoPV-N expressing HeLa cells, but did not react to empty vector,
pKS336, transfected HeLa cells (b), nor to mock HeLa cells (c). FmoPV antibody positive cat (N045, 1:40) reacted to FmoPV-N expressing HeLa cells
(d), but did not react to mock HeLa cells (e). Granular apple green signal was observed in the cytoplasm, represented by FITC
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above 1:10,000, the rabbits were euthanized and the sera
were collected. The rabbit antibodies reacted to the re-
combinant FmoPV-N protein in immunoblot (data not
shown).
Immunohistochemistry (IHC) was performed using the
rabbit FmoPV-N antibody to detect viral antigens in tis-
sues. Among 29 FmoPV-infected cats, 19 cats showed
FmoPV-N proteins in renal tissues by IHC (Table 2).
However, only four cases out of the 19 cats were positive
for FmoPV-N proteins in,the tubular cells of the renal cor-
tex and the renal medulla (Fig. 4). Extensive inflammatory
cells were infiltrated around the FmoPV-N positive renal
tubular cells, indicating the cats were suffered from
chronic tubulointerstitial nephritis (Fig. 4a and b). Al-
though other cases also showed mild to severe infiltration
of mononuclear cells in the interstitial tissues, the distri-
bution of FmoPV-N proteins was limited in renal tubular
cells or transitional cells of the renal medulla or pelvis,













1a N010 ++ P1 P >20,480 *** LC080842 N010U
2a N101 ++ P P 5120 *** LC080851 N101U
3a N153 +++ P P 640 *** LC080858 N153U
4 N007 + P P 10,240 ** LC080841 N007U
5 N110 + P P 1280 ** LC080854 N110U
6 N134 ++ P P 160 ** LC080855 N134U
7 N141 + P P 2560 * LC080856 N141U
8 N020 + P N2 5120 *
9 N050 +++ P N 640 ** LC080846 N050U
10 N104 none P N 1280 ** LC080852 N104U
11 N028 +++ N P 5120 ** LC080843 N028K
12 N040 ++ N P 1280 ** LC080844 N040K
13† N055 ++ P P <40 *** LC080847 N055U
14 N001 ++ P P <40 ** AB924120 OtJP001
15 N003 + P P <40 ** AB924121 MiJP003
16 N073 +++ P P <40 * AB924122 ChJP073
17 N076 none P P <40 ** LC080850 N076U
18 N109 ++ P P <40 * LC080853 N109U
19 N140 + N N 640 *
20 N045 ++ N P 2560 none LC080845 N045K
21 N144 +++ N P 640 none LC080857 N144K
22 N063 + N P <40 none LC080848 N063K
23 N065 + P N <40 none LC080849 N065U
24 N024 + N N 2560 none
25 N064 +++ N N 2560 none
26 N131 + N N 320 none
27 N136 ++ N N 640 none
28 N138 none N N 320 none
29 N148 ++ N N 2560 none
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but not in the inflammatory lesions (Fig. 4e and f). In all
of the cases, cytoplasms of renal tubular cells were positive
for FmoPV-N proteins and there were no specific intracy-
toplasmic or intranuclear inclusion bodies (Fig. 4). Overall,
it seemed likely that FmoPV infection might be associated
with feline urinary tract diseases including CKD or LUTD,
although it remained inconclusive whether FmoPV causes
these diseases per se or acts as a helper or bystander.
Fig. 3 The relationship between age of FmoPV-infected cats and Ab
titer. Ab titers in IF test are represented by black dots. Sera showing
Ab titers of less than 1:40 are considered negative (gray dots)
Fig. 4 IHC examination of FmoPV-infected cases. a FmoPV RNA+ and Ab + positive case (ID of cat: N101). Severe infiltration of inflammatory cells
into the interstitial tissue or renal tubules is observed (HE staining). b FmoPV RNA+ and Ab + positive case (ID of cat: N110). FmoPV antigens were
demonstrated in the cytoplasm of renal tubular cells (IHC). c FmoPV RNA+ and Ab- case (ID of cat: N055). d FmoPV RNA+ and Ab- case (ID of cat:
N055). Transitional cells in the renal pelvis are positive (IHC). e FmoPV RNA+ and Ab- case (ID of cat: N076). There are no pathologic lesions in this
case (data not shown, Table 2). f FmoPV RNA+ and Ab- case (ID of cat: N076). Renal tubular cells are positive (IHC)





1a (n) 2b 3c 4d
FmoPV-positive 3 10 16 0 29
FmoPV-negative 25 15 29 2 71
a No lesions
b Mild infiltration of inflammatory cells
c Moderate to severe TIN
d et al
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Discussion
In the present study, 22 out of 100 cats in Japan were
shown to be FmoPV RNA positive in urine and/or kidney.
Phylogenetic analysis of the FmoPV detected in Japan
showed FmoPV was clustered in three groups. However, a
phylogenetic relationship with geographic distribution of
FmoPV in Japan and Hong Kong was not observed. Fur-
ther, a significant relationship between FmoPV cluster and
renal disease in the cat was not observed (data not
shown). It is, however, necessary to compare the FmoPV
sequences in cats from other regions in future to confirm
this hypothesis. Recently, several partial sequences of
FmoPV detected in cats in Germany were reported [5],
however, we could not compare our data with them be-
cause the region of the sequences were not overlapped.
RNAs and proteins of FmoPV were detected in cat
urine, sera and/or renal tissues. Anti-FmoPV Abs were
also demonstrated in cat sera. FmoPV-infected cats in
the present study were divided into three groups: RNA
+/Ab+, RNA+/Ab- and RNA-/Ab+. Cats in the RNA
+/Ab- group were considered to be in an acute phase of
FmoPV infection. Cats in the RNA+/Ab + group were
considered to be in either a subacute or a chronic phase
of the infection. Since it is not confirmed that the nested
R-PCR used in the present study detected all the FmoPV
strains because of the genetic diversity of the viruses,
thus it is possible that there are some false negative re-
sults in the RT-PCR. Since humoral immune response in
addition to cellular immune response to the virus are
thought to eliminate the virus from animals, cats in the
RNA-/Ab + group were considered to be in a convales-
cent phase. Consequently, it appears that FmoPV could
establish as an acute, subacute or chronic infection, and
could be eliminated. Additionally, there were cases in
which RNA of FmoPV was negative in urine but positive
in renal tissues. Since approximately half of the infected
cats (14 out of the 29 infected cats) were positive for
viral RNA and Ab, it seems likely that cats are easily
chronically or persistently infected with the virus. How-
ever, further long-term follow-up studies in FmoPV-
infected cats are necessary to confirm this hypothesis.
Cat samples were collected randomly from healthy
cats and sick or wounded cats, including stray cats in
Tokyo. No relationships among the clinical data, except
age and sex, with the infection by FmoPV could be
found. The infection rate of FmoPV was significantly
high in unneutered male cats (P < 0.005) in this study
(Fig. 6). These tendencies could be due to differences of
behavior patterns, such as more aggressive or active be-
havior in unneutered male cats than neutered male cats
and female cats, and such behavior might result in an in-
crease in opportunity of infection with FmoPV from
other infected cats. The transmission of FmoPV between
cats could occur in veterinary hospitals, boarding
Table 4 The relationship between the presence of
inflammatory lesions and the infection of FmoPV
Infection of FmoPV
The presence of inflammatory lesions
Total
Existed (n) Not existed (n)
FmoPV-positive 26 3 29
FmoPV-negative 44 27 71
Fig. 5 Analysis of recombinant FmoPV-N protein. a Coomassie
Brilliant Blue (CBB) staining and Immunoblot. Two major bands were
stained with CBB (M; mock, FN; FmoPV-N) (I). A large band
corresponded to the entire FmoPV-N with a molecular weight of
59 kDa (1), while other smaller band may correspond to a truncated
FmoPV-N with a molecular weight of 40 kDa (2). FmoPV antibody
positive cat serum (N028) reacted to both two bands (II). FmoPV
antibody negative cat serum (N004) did not react to mock and
FmoPV-N protein (III). b Purity of the recombinant FmoPV-Ab. An
image of the stained gel was analyzed using ImageJ 1.50i and it was
shown that amount of the entire FmoPV-N and the truncated
protein were approximately 21 and 72 %, respectively. The purity
was estimated to be 93 %
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kennels, breeding facilities, outdoors or at home. Given
the high positive rate, it seemed that FmoPV might be
maintained between their transmissible cats for a long
time.
In a pathological examination, 25 out of 29 infected
cats had renal lesions, from mild mononuclear cell infil-
tration to chronic tubulointerstitial nephritis. Half of
them were mediate to severe cases. As a result of IHC,
19 out of 29 cats showed FmoPV-N protein in their kid-
ney tissues. Four of the 19 cats showed severe lesions
with FmoPV-N protein in the inflammatory lesions. The
FmoPV-N protein-positive cells were identified to be
renal tubular epithelial cells in the renal cortex, medulla
and pelvis. FmoPV-N protein-positive mononuclear cells
could not be found in this study, different from a report
in Hong Kong [1]. These cases had RNA of FmoPV both
in urine and renal tissues and relatively high IgG titer of
1: 640 to 20,480, except one case, representing the
chronic phase. However, the IHC-positive sites were fo-
cally located, not distributed widely in the lesions.
In the other 15 cases, normal renal tubular cells or transi-
tional cells of the renal medulla or pelvis were IHC-
positive. No statistically significant correlations were found
between the grades of lesions and the infection of FmoPV.
However, a statistically significant relationship with the
presence of inflammatory lesions and the infection of
FmoPV was found, regardless of TIN. Consequently, no
meaningful direct relationship between infection by FmoPV
and chronic TIN was confirmed in this study. It might be
plausible that FmoPV antigens in the lesions were already
eliminated by host immune responses in the case of severe
chronic TIN. A similar phenomenon was reported in other
virus infectious diseases such as hemorrhagic fever with
renal syndrome (HFRS) caused by hantavirus and severe
acute respiratory syndrome (SARS) caused by SARS cor-
onavirus (SARS-CoV) [19, 20]. In these cases, uncontrolled
responses in cytokines and chemokines are considered to
be responsible for the pathogenesis. In this regard, it would
be necessary to analyze innate immune responses in cats
with FmoPV.
It is well known that many viruses such as feline im-
munodeficiency virus, feline foamy virus, feline infec-
tious peritonitis virus and feline leukemia virus can
affect the kidneys of domestic cats, resulting in severe
CKD including glomerulosclerosis, TIN, amyloidosis and
pyrogranulomatous nephritis [21–27]. FmoPV is a re-
cently identified virus, but it could affect the kidneys in
infected cats. Thus, the existence or pathogenicity of
FmoPV could have been underestimated.
In addition, a correlation between lower urinary
tract disease (LUTD) and infection of FmoPV has
been reported recently [5]. LUTD including urethral
obstruction (UO) and interstitial cystitic (IC) is also
an important and common disease in domestic cats
[10, 11, 15–17, 28–30]. Feline calicivirus, feline her-
pesvirus type II and feline foamy virus have been de-
tected in some cats with LUTD [21, 28–32]. In this
study, lower urinary tract tissues or related clinical
symptoms were not examined. However, it could not
be excluded that FmoPV may also be related to
LUTD, for two reasons: 1) only four cases had
FmoPV antigens in inflammatory lesions of the renal
cortex, even focal, 2) normal tubular cells of the
renal medulla and transitional cells of the renal pel-
vis in proximity to the lower urinary tract were
FmoPV antigen-positive.
Genetic diversity of FmoPV has been described exten-
sively [3–5]. In Hong Kong, FmoPV seemed to be related
to chronic TIN [1]. In Germany, it was detected in a
LUTD case [5]. In addition, they detected FmoPV in a
LUTD case showing 86 ~ 99 % homology compared to
reported FmoPV [5]. At the moment, we could not de-
tect FmoPV belonging to genetically diverged group
found in Germany [5] among cats in Japan. We can not
rule out the possibility that our RT-PCR and IHC could
not detected these FmoPV RNA and N protein and their
antibodies could not be detected using N proteins of
FmoPV belonging to cluster C. However, it is unlikely
since N proteins of paramyxoviruses in the same species
are highly conserved and cross-reactive.
Fig. 6 FmoPV-infected cats according to sex. The infection rate of FmoPV was significantly high in unneutered male cats (P < 0.005)
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In our study, no clear relationship between FmoPV
and chronic TIN or LUTD could be clarified although
many types of FmoPV-infected cases are described.
It was suggested that FmoPV infection has a signifi-
cant relationship with inflammatory reactions in the fe-
line kidney and may be associated with urinary tract
diseases. This was the first epidemiological report in-
cluding seroprevalence and pathological examination of
FmoPV among domestic cats in Japan. Considering the
high infection rate and the genetic diversity of FmoPV, it
seemed likely that FmoPV has evolved in Japan over a
long period. Further retrospective and larger scale stud-
ies, including pathological studies, in other organs of
cats are needed to elucidate the pathogenicity of FmoPV
in cats.
Conclusions
In this study, a high prevalence of FmoPV infection in do-
mestic cats in Japan was revealed, and a significant relation-
ship between FmoPV infection and inflammatory lesions in
the kidneys was found. Further studies are necessary to elu-
cidate the etiology of FmoPV in domestic cats. The sero-
logical and pathological examination established in this
study might be useful for further surveillance.
Methods
Cat samples
Post-mortem urine (n = 100), sera (n = 100) and renal
tissue samples (n = 100) were obtained from cats housed
in the Tokyo Metropolitan Animal Care and Consult-
ation Center. Cats in the center were carried by owners
or captured in outdoors in Tokyo. Physical state and
clinical symptoms were examined and recorded at the
center. Cats randomly selected in the present study were
healthy, sick or wounded, varying in age from new-born
to 20 years old. The sex ratio of cats used in this study
was similar.
Detection of FmoPV
Total RNAs were extracted from cat urine (100 μL) and
renal tissue samples (randomly selected three sites) using
ISOGEN (Wako, Osaka, Japan) and a precipitation car-
rier (Ethachinmate, Wako), according to the manufac-
turer’s instructions. In the reverse transcription reaction,
cDNA was synthesized by random primers (SuperScript
R III First-strand synthesis supermix, Invitrogen, CA,
USA) from the extracted RNA. Then, a part of L-gene
sequence of FmoPV with 401 bp was amplified by nested
polymerase chain reaction (PCR, 94 °C 5 min/94 °C
15 s, 55 °C 30 s, 68 °C 1 min/68 °C 5 min, first PCR :
40 cycles, second PCR : 20 cycles) using puRe Taq
ready-to-go PCR beads (GE Healthcare, Buckingham-
shire, UK) according to the previous reports [2, 4]. The
primer sets used in the nested RT-PCR were previously
reported [2]. A PCR product amplified from a FmoPV
positive cat was purified and cloned into the pCR™ 4-
TOPO® vector (Invitrogen) and used as a positive con-
trol of the nested RT-PCR. The sensitivity of the nested
RT-PCR was approximately 10 copies /reaction (data not
shown).
Phylogenetic analysis
RT-PCR amplicons were separated by agarose gel electro-
phoresis and purified from the agarose gel using illustra™
GFX™ PCR DNA and Gel Band Purification Kit (GE
Healthcare), according to the manufacturer’s instruction.
The purified RT-PCR amplicons were used as templates for
sequencing on an ABI 3130 Genetic Analyzer (Applied Bio-
systems) using a BigDye Terminator v3.1 cycle sequencing
kit (Applied Biosystems, CA, USA) with the first and sec-
ond PCR primers. Phylogenetic analysis was performed ac-
cording to previous reports [4, 33, 34]. Briefly, phylograms
were constructed using with the maximum likelihood
method with the Kimura two-parameter model included in
the MEGA6 package. The robustness of the resulting
branching patterns was tested using the bootstrap method
with 1000 replicates. In the analysis, the sequences of
FmoPV (Hong Kong : M252A, 761U and 776U, Japan :
SS1, OtJP001, MiJP003 and ChJP073, outgroups : CDV-
Acc.No. AB476401.1 and Nipah virus-Acc.No. JN808863.1)
deposited in the GenBank were included in the analysis. To
support the result of phylogenetic tree, pairwise distances
were analyzed by MEGA6 package and a distribution of
pairwise distances was represented by histogram [18]. Sta-
tistically significant differences were calculated by Welch’s t
test.
FmoPV-N protein-expressing HeLa cells
Since the nucleocapsid (N) protein of morbilliviruses is
highly conserved among isolates and has immunogenic
epitopes [35–37], a full-length N protein of FmoPV (761U
strain, JQ411014) was expressed in HeLa cells. A plasmid
pMK-RQ containing FmoPV-N cDNA was chemically
synthesized (Life Technologies, Tokyo, Japan). FmoPV-N
cDNA with a BamHI restriction site sequence at each ex-
tremity was amplified by polymerase chain reaction (PCR)
from pMK-RQ containing FmoPV-N cDNA using an N-
BamHI-F primer 5’-AGG ATC CAC AAT GTC TAG
TCT ATT GAG G-3’ and N-BamHI-R 5’-TGG ATC CAG
TTA TTT TAG AAG GTC AGT-3’ and cloned into a
BamHI site of pKS336 expression vector [38]. The result-
ant vector, pKS336-FmoPV/N, was transfected into HeLa
cells, and selected by DMEM medium containing 5 % fetal
calf serum (FCS) and Blasticidin S Hydrochloride (2 μg/
ml, Kaken Pharmaceutical. Co, Tokyo, Japan). The gener-
ated FmoPV-N-expressing HeLa cells were mixed with
mock HeLa cells at 1:1, spotted on 14-well HT-coated
slide glasses (AR Brown, Tokyo, Japan), air dried and fixed
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with acetone at room temperature for 5 min and stored at
-80 °C until use. The antigen slides were used for the im-
munofluorescence test described below.
Preparation of rabbit antibody against FmoPV-N protein
Recombinant FmoPV-N protein with a histidine (His)-tag
at C-terminal was prepared by a baculovirus expression
vector system to obtain rabbit antibody against FmoPV-N
protein. First, to construct the expression plasmid, cDNA
of FmoPV-N protein (761U strain, Accession No.
JQ411014) was amplified by PCR using N-BamHI-F and
N-BamHI-R primers and cloned into a transfer vector,
pAcYM1-His-C. To construct the recombinant baculo-
virus containing FmoPV-N cDNA, the resulting transfer
vector, pAcYM1-His-C-FmoPV/N, was co-transfected
with a linearized baculovirus DNA, BaculoGold™ DNA
(BD Biosciences, San Jose, CA) using X-treme 9 GENE
Transfection solution (Roche, Mannheim, Germany) into
Sf9 insect cells. The cells were cultured in Sf-900 TM II
SFM Complete × 1 (Gibco, NY, USA) with 10 % FCS and
kanamycin for 7 days at 27 °C. The medium and cells were
harvested and centrifuged at 3000 rpm for 10 min at room
temperature. The supernatants containing recombinant
baculovirus-FmoPV/N were collected and saved at 4 °C.
The cell pellets were used in SDS-PAGE to confirm the
expression of his-tagged FmoPV-N protein. Baculovirus-
FmoPV/N was infected to Tn5 cells to express his-tagged
FmoPV-N protein. Infected Tn5 cells were harvested at
3 days post-infection and his-tagged FmoPV-N protein
was purified by Ni-NTA agarose (QIAGEN, Hilden,
Germany) and His-Bind® buffer kit (Novagen, San Diego,
CA, USA). Purity of the purified FmoPV-N protein was
analyzed by SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) followed by Coomassie Brilliant Blue staining (Bio-
Safe TM Coomassie G-250 stain, Bio-Rad, CA, USA).
Stained bands were quantified using ImageJ 1.50i [39, 40].
The purified FmoPV-N protein was subcutaneously
injected into three rabbits five times. When the serum
antibody titer checked by IF reached above 1:10,000, the
rabbits were euthanized and sera were collected.
They reacted with FmoPV-positive renal tissues by IF,
IHC and immunoblot, but did not react with FmoPV-
negative renal tissues.
Immunoblot
The purified recombinant FmoPV-N protein with His-tag
was separated by SDS-PAGE and electrophoretically
transferred to Immu-Blot PVDF membranes (Bio Rad,
CA, USA). The membranes were blocked with Blocking
One (Nacalai tesque, Inc. Kyoto, Japan) at 4 °C overnight
and were incubated with cat sera (FmoPV-N Ab-positive;
N028, FmoPV-N Ab-negative; N004) at a dilution of 1:500
at room temperature for 2 h. Then, the membranes were
incubated with horse radish peroxidase-conjugated
recombinant protein A/G (Purified Recomb ® Protein A/
G, peroxidase-conjugated, Thermo Scientific, MA, USA)
at a dilution of 1:1000 at room temperature for 1 h. The
reaction of the antibodies were visualized with EzWest-
Blue (ATTO Corporation, Tokyo, Japan).
Immunofluorescence (IF) test
IF was performed to detect antibodies (Ab) to FmoPV-N
protein in cat sera. Cat sera were serially diluted in
phosphate-buffered saline (PBS (-)) at a dilution of 1;40
to 1;20,480. They were applied to the wells of the anti-
gen slides described above, and reacted for 1 h at 37 °C
in a humidified chamber. After washing in PBS(-), goat
anti-cat-IgG (H + L) conjugated with fluorescein (FITC)
(1:1000, ROCKLAND, Gilbertsville, PA) was applied and
incubated for 40 min at 37 °C. IF test was performed
three times for each cat serum. Rabbit antibodies against
FmoPV-N protein and goat anti-rabbit-IgG (H + L) con-
jugated with FITC were used as the positive control.
Pre-sera from the same rabbits were used as negative
controls. After washing in PBS(-), the slides were exam-
ined for staining patterns under a fluorescent micro-
scope (Olympus BX51 and Olympus DP Controller 1. 1.
1.65 (Olympus, Tokyo, Japan). The Ab titers of tested
cat sera were recorded as the reciprocals of the highest
dilutions producing positive staining.
Histopathological examination
Three sites including the renal cortex, medulla and pel-
vis were collected randomly and fixed in 10 % neutral
formalin solution. Fixed tissues were embedded in paraf-
fin, sectioned, and stained with hematoxylin and eosin
(HE). For immunohistochemistry (IHC), deparaffinized
sections were autoclaved at 121 °C for 10 min for anti-
gen retrieval. Endogenous peroxidase activity was
blocked by incubating sections with 3 % hydrogen per-
oxide in methanol at room temperature for 5 min. For
the tissue blocking, sections were treated with 10 %
skimmed milk in PBS(-) at 37 °C for 40 min. Then,
rabbit antibodies against FmoPV-N protein (1:500 to
1:1000) were applied as primary antibodies at 4 °C over-
night. Thereafter, sections were incubated with Envision
System HRP-labeled polymer anti-rabbit (DAKO Japan,
Kyoto, Japan) at room temperature for 40 min. Finally,
the sections were visualized with 3,3’-diaminobenzidine
tetrahydrochloride (Wako, Japan), and counterstained
with Mayer’s hematoxylin solution (Wako). Degree of le-
sions was scored by severity of the lesions based on de-
gree and extensiveness of tubulointerstitial nephritis or
infiltration of inflammatory cells and other associated
findings including interstitial fibrosis, necrotic changes,
glomerulosclerosis and calcification. Scoring criterion +
was defined as mild lesion with focal infiltration of small
inflammatory cells. Scoring criterion ++ was defined as
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moderate lesion with infiltration of moderate inflamma-
tory cells. Scoring criterion +++ was defined as severe
lesions with severe infiltration of inflammatory cells.
Distribution of FmoPV-N antigens in the renal tissues
by IHC were also scored. Scoring criterion * was defined
as FmoPV-N antigen positive cells focally in normal
renal tissues, and criterion ** was defined as FmoPV an-
tigens in several sites, while criterion *** was defined as
extensive FmoPV antigen positive cells around lesions.
Statistical analysis
Results are expressed as the number of cases. Statistical
analyses were performed using StatFlex software (ver. 6,
Artech Co., Ltd., Osaka, Japan). Significant differences
between groups were determined by the Mann-Whitney
U-test and ϰ2 test.
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